News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Yuchen Liu/sightmd.com
Nov 2, 2024, 17:34

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a recent article by Yuchen Liu on X:

“Very interesting study in Blood Journal looking at Pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)!”

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax in relapsed or refractory acute myeloid leukemia.

Authors: Yuchen Liu, et al.

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

 

Acute Myeloid Leukemia AML Anand Patel Blood Journal cancer OncoDaily Oncology Pegcrisantaspase venetoclax Yuchen Liu
Special Coverage
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story
Blog
Dec 21, 2024, 11:24
Christy Brown: How many things can you dread more than 'your child has aggressive brain cancer?'
Blog
Dec 21, 2024, 11:18
Jose Fernando Moura: Pivotal SABCS24 summary hosted by Cancer Network
Blog
Dec 21, 2024, 11:18
Jérôme Salomon: President Macron, WHO Director-General and global health leaders inaugurate WHO Academy
Blog
Dec 21, 2024, 11:17
ChatGPT-Like AI Tool Promises to Speed Treatment Advances and Free Doctors’ Time by Matching Patients with Clinical Trials
Blog
Dec 21, 2024, 11:14
Mediamedic - Wenbin Zhou on Pyrotinib-based regimen in HER2-positive breast cancer
Blog
Dec 21, 2024, 11:12
Didier Verhoeven: Comparing survival in breast cancer in Belgian Breast Centres